Exploiting CD36 as a self-facilitated endocytic receptor for PROTAC-mediated protein degradation: A new paradigm in cancer therapy

Critical Reviews in Oncology/Hematology 2026

View at publisher

Authors: Jiayan Gu, Mingyu He, Weimei Wang, Jiali Hu, Xinfeng Yang, Mingkai Lai, Siyu Li, Xiaobing Duan, Qiong Luo, Guihai Zhang

DOI: 10.1016/j.critrevonc.2026.105384

Cited by: 1

References: 85

Fields of Study & Subjects

Protein Degradation and Inhibitors Peptidase Inhibition and Analysis HER2/EGFR in Cancer Research

References 85